Evidence map›Paper›PMID 31617105›Full record

ReviewMycopathologia2020

Molecular Typing of Candida glabrata.

Toni Gabaldón, Emilia Gómez-Molero, Oliver Bader

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mycopathologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Molecular epidemiology ofVirulence · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. OverlookedbioRxiv : the preprint server for biology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Anti-Candidal Activity of the Parasitic PlantAntibiotics (Basel, Switzerland) · 2021
    Article
  14. Pharmaceutics · 2021
    Review
  15. Comparative genomic analysis of clinicalStudies in mycology · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Toni GabaldónComparative Genomics Group, Life Science Programme, Barcelona Supercomputing Centre (BSC-CNS), Barcelona, Spain.
Emilia Gómez-MoleroInstitute for Medical Microbiology, University Medical Center Göttingen, Kreuzbergring 57, 37075, Göttingen, Germany.
Oliver BaderInstitute for Medical Microbiology, University Medical Center Göttingen, Kreuzbergring 57, 37075, Göttingen, Germany. obader@gwdg.de.ORCID http://orcid.org/0000-0002-1534-440X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The yeast Candida glabrata has emerged, second only to Candida albicans, to be one of the most frequently isolated fungi in clinical specimen from human. Its frequent resistance towards azole antifungal drugs and the high capacity to form biofilms on indwelling catheters of individual isolates render it an often difficult to treat pathogen. Hence, there is a notably increasing scientific and clinical interest in this species. This has led to the development of a variety of molecular tools for genetic modification, strain collections, and last but not least different approaches to analyse the population structure among isolates of different geographical and clinical contexts. Often, these are used to study correlations (or the absence thereof) with different pathogenicity, virulence, or drug resistance traits. Three molecular methods have been used to type within the C. glabrata population on a genetic level by multiple studies: multi-locus sequence typing, microsatellite length polymorphisms, and clustering of whole-genome sequencing data, and these are subject of this review.

Indexed as

Antifungal AgentsCandida glabrataCandidiasisDNA ProbesDrug Resistance, FungalGenes, FungalGenome, FungalGenotyping TechniquesHumansMicrosatellite RepeatsMultilocus Sequence TypingMycological Typing TechniquesWhole Genome SequencingAntifungal AgentsDNA ProbesCandida glabrataMicrosatellite typing (MLP)Multi-locus sequence typing (MLST)pubmlst.orgWhole-genome sequencing (WGS)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.